BioLife Solutions Inc (BLFS)
Return on total capital
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | -7,129 | -70,825 | -145,541 | -35,160 | -6,241 |
| Long-term debt | US$ in thousands | 4,997 | 17,561 | 23,793 | 6,353 | 655 |
| Total stockholders’ equity | US$ in thousands | 348,909 | 337,663 | 364,188 | 478,047 | 204,429 |
| Return on total capital | -2.01% | -19.94% | -37.51% | -7.26% | -3.04% |
December 31, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $-7,129K ÷ ($4,997K + $348,909K)
= -2.01%
BioLife Solutions Inc has experienced a declining trend in its return on total capital over the past five years, from -3.04% in December 31, 2020 to -2.01% in December 31, 2024. The company's return on total capital was negative throughout this period, indicating that it has not been effectively utilizing its capital to generate profits. The significant decrease in the return on total capital from -3.04% in 2020 to -37.51% in 2022 suggests potential challenges in the company's operational efficiency and profitability. It is essential for BioLife Solutions Inc to assess and address the underlying factors contributing to the declining return on total capital to improve its financial performance and optimize capital allocation strategies in the future.
Peer comparison
Dec 31, 2024